title: Antisense IGF and antisense IGF-IR therapy of malignancy.
authors.affiliation: Shanghai International Joint Cancer Institute, Second Military Medical University, Shanghai, P. R. China.
authors.forename: H
authors.initials: H
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: L
authors.initials: L
authors.lastname: Wei
authors.forename: Y
authors.initials: Y
authors.lastname: Guo
mesh_terms: D000818:Animals; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000235:genetics* / Q000378:metabolism; D007335:Insulin-Like Growth Factor II / Q000378:metabolism; D020319:Oligodeoxyribonucleotides, Antisense; D016372:RNA, Antisense; D017526:Receptor, IGF Type 1 / Q000235:genetics*; D017527:Receptor, IGF Type 2 / Q000378:metabolism
chemical_list: D020319:Oligodeoxyribonucleotides, Antisense; D016372:RNA, Antisense; D017527:Receptor, IGF Type 2; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D017526:Receptor, IGF Type 1